FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

FHIR IG Statistics (922 ms)

Resources - All Kinds, Realm EU, Authority Hl7

1038 resources

Type:
Text: Use quotation marks (") for an exact phrase. You can use AND, OR, and NOT. Wildcard = *

By Version

Start Prev Rows 400 - 600 Next
PackageVersionIdentityName/TitleStatusDate
hl7.eu.fhir.idea4rcR4StructureDefinition/sarcoma-extent-category Observation: Localized Category (Stage, Sarcoma)draft2024-11
hl7.eu.fhir.idea4rcR4StructureDefinition/sarcoma-locoRegional-category Observation: LocoRegional Category (Stage, Sarcoma)draft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/Gender-i4rc Gender: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/alcoholUsageStatus-athena-eu-i4rc Alcohol Usage Status: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/alcoholUsageStatus-snomed-eu-i4rc Alcohol Usage Status: SNOMED CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/beam-quality-i4rc Beam Qualityactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-chondroOsseousTumours-athena-vs Cancer Chondro Osseous Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-diagnosis-athena-vs Cancer diagnosis: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-estAndRelatedTumours-athena-vs Cancer Endometrial stromal and related Tumors: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-event-type-vs Cancer Event Type: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologyAdenocarcinoma-athena-vs Cancer Histology Adenocarcinoma: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologyNeuroendocrine-athena-vs Cancer Histology Neuroendocrine: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologyOdontogenicCarcinoma-athena-vs Cancer Histology Odontogenic Carcinoma: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologySNUC-athena-vs Cancer Histology SNUC: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologySquamous-athena-vs Cancer Histology Squamous: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologySubgroupAdipocyticTumours-athena-vs Cancer Histology Subgroup Adipocytic Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-histologySubgroupFmtTumours-athena-vs Cancer Histology Subgroup Fmt Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-miscellaniousMesenchimalTumors-athena-vs Cancer Miscellanious mesenchimal tumors: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-mixedEpithelialAndMesenchymalTumours-athena-vs Cancer Mixed epithelial and mesenchymal tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-pericyticPerivascularTumours-athena-vs Cancer Pericytic Perivascular Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-peripheralNerveSheathTumours-athena-vs Cancer Peripheral Nerve Sheath Tumors: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-skeletalMuscleTumours-athena-vs Cancer Skeletal Muscle Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-smoothMuscleTumours-athena-vs Cancer Smooth Muscle Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-socalledFibrohistiocyticTumours-athena-vs Cancer Histology Subgroup So called Fibrohistiocytic Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-stageGrading-athena-vs Cancer Stage Grading: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-stageGroup-athena-vs Cancer Stage Group: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-stageGroupValue-athena-vs Cancer Stage Group Value: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-tumoursOfUncertainDifferentiation-athena-vs Cancer Tumors Of Uncertain Differentiation: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-undifSmallRCelSarcBonAndSofTis-athena-vs Cancer undif. small round cell sarcomas of bone and soft tissue: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/cancer-vascularTumours-athena-vs Cancer Vascular Tumours: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/chemo-units-eu-i4rc Chemotherapy cumulative dose unitsdraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/comorbidities-athena-eu-i4rc Comorbidities: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/comorbidities-sct-eu-i4rc Comorbidities: SNOMEDactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/country-eu-i4rc Country: athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/disease-extent-category-vs Sarcoma Staging: localized diseasedraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/drugsAtc-eu-i4rc Antineoplastic and immunostimulating agentsdraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/ecog-i4rc ECOG Performance Statusactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/event-type-eu-i4rc Event Typeactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/extranodal-extension-i4rc Extranodal Extensiondraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/geneticTestPerformed-eu-i4rc Genetic Tests performed (Yes/no/Unk)active2024-11
hl7.eu.fhir.idea4rcR4ValueSet/genito-urinary-subsite-athena-i4rc Genito urinary subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/hypopharynx-subsite-athena-i4rc Hypopharynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/hypopharynx-subsite-sct-i4rc Hypopharynx subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/intra-abdominal-subsite-athena-i4rc Intra abdominal subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/intra-thoracic-subsite-athena-i4rc Intra thoracic subsite : Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/larynx-subsite-athena-i4rc Larynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/larynx-subsite-sct-i4rc Larynx subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/lip-subsite-athena-i4rc Lip subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/lip-subsite-sct-i4rc Lip subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/locoregional-category-vs Sarcoma Staging: loco-regional categorydraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/margins-after-surgery-eu-i4rc Margins After Surgeryactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/mcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/mcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/mcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-distant-metastases-category-vs TNM Distant Metastases Category Value Setdraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-primary-tumor-category-vs TNM Primary Tumor Category Value Setdraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/mcode-tnm-regional-nodes-category-vs TNM Regional Nodes Category Value Setdraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/metastasis-disorder-athena-vs Metastatis: Athenadraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/nasal-paranasal-subsite-athena-i4rc Nasal cavity and paranasal sinuses subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/nasal-paranasal-subsite-sct-i4rc Nasal cavity and paranasal sinuses subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/nasal-subsite-athena-i4rc Subsites: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/nasal-subsite-sct-i4rc Subsites: SNOMED CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/nasopharynx-subsite-athena-i4rc Nasopharynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/nasopharynx-subsite-sct-i4rc Nasopharynx subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/obsYesNo-code-eu-i4rc Types of Yes/No observationsactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/occurrence-other-cancer-i4rc Occurrence of other canceractive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/oralCavity-subsite-athena-i4rc Oral cavity subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/oralCavity-subsite-sct-i4rc Oral cavity subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/oropharynx-subsite-athena-i4rc Oropharynx subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/oropharynx-subsite-sct-i4rc Oropharynx subsite: Snomed CTactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/pathologicalM-i4rc Pathological Mactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/pathologicalN-i4rc Pathological Nactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/pathologicalT-i4rc Pathological Tactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/pos-neg-nt-athena-eu-i4rc Positive-Negative-No Test: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/race-i4rc Raceactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/reason-for-end-of-treatment-eu-i4rc Reason For End Of Treatmentactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/setting-radiotherapy-i4rc Setting Radiotherapyactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/simpleResult-eu-i4rc Simple measuresactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/site-of-metastasis-i4rc Site of metastasisactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/site-qualifier-i4rc Body site qualifieractive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/siteRare-i4rc Site rare (IDEA4RC)active2024-11
hl7.eu.fhir.idea4rcR4ValueSet/smokingStatus-athena-eu-i4rc Current Smoking Status: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/smokingStatus-loinc-eu-i4rc Smoking Status: LOINCactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/status-last-followup-i4rc Status at the Last Follow Upactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/surgery-complication-eu-i4rc Surgery Complicationactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/surgery-intention-eu-i4rc Surgery Intentionactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/surgery-outcome-eu-i4rc Surgery Outcomeactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/surgical-complications-eu-i4rc Surgical Complicationsactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/tobacco-product-eu-i4rc Tobacco Productactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/treatment-completed-as-planned-i4rc Treatment completed as plannedactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/treatment-response-eu-i4rc Treatment Responseactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/treatment-setting-eu-i4rc Treatment Settingactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/treatment-technique-i4rc Treatment Techniqueactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/trunk-wall-subsite-athena-i4rc Trunk wall subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/type-of-biopsy-eu-i4rc Type of Biopsyactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/type-of-diagnosis-eu-i4rc Type of Diagnosisactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/type-of-surgical-approach-eu-i4rc Type of surgical approachactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/type-of-systemic-treatment-eu-i4rc Type of Systemic Treatmentactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/type-of-treatment-eu-i4rc Type of Treatmentactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/upperLower-limbs-subsite-athena-i4rc Upper and Lower limbs subsite: Athenaactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/vs-affectedOrgan-eu-i4rc Affected Organs (surgery)active2024-11
hl7.eu.fhir.idea4rcR4ValueSet/vs-calcest-eu-i4rc Calculated|Estimateddraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/vs-npunk-eu-i4rc Not Performed|Unknowndraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/vs-radiotherapyDeviceType-eu-i4rc Radiotherapy Device Typedraft2024-11
hl7.eu.fhir.idea4rcR4ValueSet/vs-surgicalProcedureCategory-eu-i4rc Surgical Procedure Categoryactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/vs-surgicalProcedureType-eu-i4rc Surgical Procedure Typeactive2024-11
hl7.eu.fhir.idea4rcR4ValueSet/yes-no-unk-athena-eu-i4rc Yes-No-Unk: Athenaactive2024-11
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000093533 ATC Human EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000072052 Marketing Status EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000008 Combination Package EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000006 Combined Pharmaceutical Dose Form EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000007 Combined Term EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000000002 Country EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000000004 Domain EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000072057 Language EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000072051 Legal Status for the Supply EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000003199 Material EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000073346 Packaging EMA SPORdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000004 Pharmaceutical Dose Form EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000005003 Record Status EMA SPORdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000072049 Regulatory Entitlement Status EMA SPORdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000073345 Routes and Methods of Administration EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v2/SubstanceDefinition Substances EMA SPOR SMSdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/100000110633 Unit of Measurement EMAdraft2024-10
hl7.eu.fhir.unicomR5https://spor.ema.europa.eu/v1/lists/200000000014 Unit of Presentation EMAdraft2024-10
hl7.eu.fhir.unicomR5ConceptMap/edqm-ema-pharmaceuticalDoseForm-cm EDQM-SPOR Pharmaceutical dose formsdraft2024-10
hl7.eu.fhir.unicomR5ConceptMap/sms-snomed-substance-cm SPOR-SNOMED CT substancesdraft2024-10
hl7.eu.fhir.unicomR5ImplementationGuide/hl7.eu.fhir.unicom UnicomIGdraft2024-10
hl7.eu.fhir.unicomR5OperationDefinition/Equivalent Equivalent Look Upactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/Manufactured-item-packaging-ppd manufactured-item-packaging-ppdactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/Manufactured-item-ppd manufactured-item-ppdactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/country countryactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/name-language-correct name-language-correctactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/reference-strength-substance reference-strength-substanceactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/strength-presentation-quantity strength-presentation-quantityactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/strength-presentation-ratio-denominator strength-presentation-ratio-numeratoractive2024-10
hl7.eu.fhir.unicomR5SearchParameter/strength-presentation-ratio-numerator strength-presentation-ratio-numeratoractive2024-10
hl7.eu.fhir.unicomR5SearchParameter/strength-presentation-ratio strength-presentation-ratioactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/strength-quantity-and-substance strength-quantity-and-substanceactive2024-10
hl7.eu.fhir.unicomR5SearchParameter/strength-ratio-and-substance strength-ratio-and-substanceactive2024-10
hl7.eu.fhir.unicomR5StructureDefinition/AD ADdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/ANY ANYdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/BL BLdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/CD CDdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/Class Classdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/CrossBorderProduct DRAFT: Medicinal Product in crossborder eP/eDdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/DT DTdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/EN ENdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/FullMedicinalProduct Medicinal Product Logical Modeldraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/II IIdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/INT INTdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/ManufacturedMaterial DRAFT: MyHealth@EU medicinal productdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/MedicationAsManufacturedItem Medication as manufactured itemdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/MedicationAsMedicinalProduct Medicationdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/MedicationModel Medication for clinical workflowsdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLAdministrableProductDefinition PPL Administrable Product profiledraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLIngredient PPL Ingredient profiledraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLManufacturedItemDefinition PPL Manufactured Item profiledraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLMedicinalProductDefinition PPL Medicinal Product profiledraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLOrganization PPL Organizationdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLPackagedProductDefinition PPL Packaged Product profiledraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PPLRegulatedAuthorization PPL Marketing Authorisation profiledraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/PQ PQdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/REAL REALdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/RTO RTOdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/ST STdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/SctClinicalDrug SNOMED CT Clinical Drugdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TS TSdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionAdministrableProductDefinition Processing Profile - Administrable Productdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionIngredient Processing Profile - Ingredientdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionManufacturedItemDefinition Processing Profile - Manufactured Itemdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionMedicinalProductDefinition Processing Profile - Medicinal Productdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionOrganization Processing Profile - Organizationdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionPackagedProductDefinition Processing Profile - Packaged Productdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/TransitionRegulatedAuthorization Processing Profile - Marketing Authorisationdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/Untyped Untypeddraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/administrable-doseform AdministrableDoseFormdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/medicinal-product-classification MedicinalProductClassificationdraft2024-10
hl7.eu.fhir.unicomR5StructureDefinition/medicinal-product-name MedicinalProductNamedraft2024-10
hl7.eu.fhir.unicomR5ValueSet/administration-device EDQM Administration Deviceactive2024-10
hl7.eu.fhir.unicomR5ValueSet/administration-method EDQM Administration Methodactive2024-10
hl7.eu.fhir.unicomR5ValueSet/all-units-vs EMA SPOR All Units Combineddraft2024-10
hl7.eu.fhir.unicomR5ValueSet/atc-spor-vs EMA SPOR ATCdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/authorised-doseform-vs EMA SPOR Authorised Dose Formdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/basic-dose-form EDQM Basic Dose Formactive2024-10
hl7.eu.fhir.unicomR5ValueSet/closure EDQM Closureactive2024-10
hl7.eu.fhir.unicomR5ValueSet/combination-pack EDQM Combination Packactive2024-10
hl7.eu.fhir.unicomR5ValueSet/combined-pharmaceutical-dose-form EDQM Combined Pharmaceutical Dose Formactive2024-10
hl7.eu.fhir.unicomR5ValueSet/combined-term EDQM Combined Termactive2024-10
hl7.eu.fhir.unicomR5ValueSet/container EDQM Containeractive2024-10
hl7.eu.fhir.unicomR5ValueSet/country-ema-vs EMA SPOR Countrydraft2024-10
hl7.eu.fhir.unicomR5ValueSet/country-iso-vs Country (ISO 3166-1-2)draft2024-10
hl7.eu.fhir.unicomR5ValueSet/domain-vs EMA SPOR Domaindraft2024-10
hl7.eu.fhir.unicomR5ValueSet/ehdsi-ucum-unit MyHealth@EU Unit of Measurement (UCUM)active2024-10
hl7.eu.fhir.unicomR5ValueSet/intended-site EDQM Intended Siteactive2024-10
hl7.eu.fhir.unicomR5ValueSet/language-bcp-vs Language (FHIR)draft2024-10
hl7.eu.fhir.unicomR5ValueSet/language-ema-vs EMA SPOR Languagedraft2024-10
hl7.eu.fhir.unicomR5ValueSet/legal-status-for-the-supply-vs EMA SPOR Legal Status for the Supplydraft2024-10
hl7.eu.fhir.unicomR5ValueSet/marketing-status-spor-vs EMA SPOR Marketing Statusdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/material-vs EMA SPOR Materialdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/packaging-category EDQM Packaging Categoryactive2024-10
hl7.eu.fhir.unicomR5ValueSet/packaging-spor-vs EMA SPOR Packagingdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/patient-friendly-term EDQM Patient-friendly Termactive2024-10
hl7.eu.fhir.unicomR5ValueSet/pharmaceutical-dose-form EDQM Pharmaceutical Dose Formactive2024-10
hl7.eu.fhir.unicomR5ValueSet/pharmaceutical-doseform-vs EMA SPOR Pharmaceutical Dose Formdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/record-status-spor-vs EMA SPOR Record Statusdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/regulatory-status-spor-vs EMA SPOR Regulatory Entitlement Statusdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/route-of-administration EDQM Route of Administrationactive2024-10
hl7.eu.fhir.unicomR5ValueSet/routes-and-methods-of-administration-vs EMA SPOR Routes and Methods of Administrationdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/shelflifetype-spor-vs EMA SPOR Shelf Life Typedraft2024-10
hl7.eu.fhir.unicomR5ValueSet/substances-vs EMA SPOR SMS Substancesdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/unit-of-measurement-vs EMA SPOR Unit of Measurementdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/unit-of-presentation-vs EMA SPOR Unit of Presentationdraft2024-10
hl7.eu.fhir.unicomR5ValueSet/unit-of-presentation EDQM Unit of Presentationactive2024-10
hl7.eu.fhir.unicomR5ValueSet/whoatc-unicom WHO ATCactive2024-10
hl7.fhir.eu.laboratoryR4http://example.org/lab-codes Laboratory Code: exampledraft2024-12
hl7.fhir.eu.laboratoryR4ConceptMap/ConceptMap-eu-diagRptStatus2CompStatus DiagnosticReport to Composition statusdraft2024-12
hl7.fhir.eu.laboratoryR4ConceptMap/author2FHIR-eu-lab eHN Author to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryR4ConceptMap/labRpt2FHIR-eu-lab eHN Lab Report to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryR4ConceptMap/legalAuth2FHIR-eu-lab eHN Recipient to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryR4ConceptMap/order2FHIR-eu-lab eHN Order to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryR4ConceptMap/payer2FHIR-eu-lab eHN Payer to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryR4ConceptMap/recipient2FHIR-eu-lab eHN Recipient to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryR4ConceptMap/result2FHIR-eu-lab eHN Result to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryR4ConceptMap/specimen2FHIR-eu-lab eHN Specimen to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryR4ConceptMap/subject2FHIR-eu-lab eHN Subject to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryR4ConceptMap/validator2FHIR-eu-lab eHN Validator to this guide Mapdraft2024-12
hl7.fhir.eu.laboratoryR4ImplementationGuide/hl7.fhir.eu.laboratory HL7 Europe Laboratory Reportdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Address-eu Address (EU)draft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Author A.1.5 - Authordraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/BodyStructure-eu-lab Body structure: Laboratorydraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Bundle-eu-lab Bundle: Laboratory Reportdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Composition-eu-lab Composition: Laboratory Reportdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/DiagnosticReport-eu-lab DiagnosticReport: Laboratory Reportdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/HumanName-eu HumanName (Eu)draft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/HumanName-obl-eu-lab Human Name: Obligationsdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/LabReport A - Laboratory Reportdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/LegalAuthenticator A.1.6 - Legal authenticatordraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Observation-obl-eu-lab Observation: Obligationsdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Observation-resultslab-eu-lab Observation Results: laboratorydraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Order A2, A3 - Orderdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Patient-animal-eu-lab Patient: Animaldraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Patient-obl-eu-lab Patient: Obligationsdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Payer A.1.3 - Health insurance and payment informationdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Quantity-eu-lab Quantity (Eu Lab)draft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Ratio-eu-lab Ratio (Eu Lab)draft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Recipient A.1.4 - Information recipientdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Result A.5 - Results data elementsdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/ServiceRequest-eu-lab ServiceRequest: Laboratory Orderdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/ServiceRequest-obl-eu-lab ServiceRequest: Obligationsdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Specimen-eu-lab Specimen: Laboratorydraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Specimen-obl-eu-lab Specimen: Obligationsdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/SpecimenLab A.4 - Specimen informationdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Subject A1.1, A1.2 - Subject of caredraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Substance-additive-eu-lab Substance: Specimen Additive Substancedraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/Validator A.1.7 - Result validatordraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/composition-diagnosticReportReference Document DiagnosticReport Referencedraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/observation-certifiedRefMaterialCodeable Certified Reference Material: CodeableConceptdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/observation-certifiedRefMaterialIdentifer Certified Reference Material: Identifierdraft2024-12
hl7.fhir.eu.laboratoryR4StructureDefinition/observation-deviceLabTestKit Device Laboratory Test Kitdraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-certifiedRefMaterial-eu-lab Laboratory Certified Reference Materialdraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-laterality-eu-lab Body Structure Lateralitydraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-obsCode-eu-lab Laboratory Codedraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-obsCode-loinc-eu-lab Laboratory Code: LOINCdraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-obsCode-npu-eu-lab Laboratory Code: NPUdraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-orderCodes-eu-lab Laboratory Orderdraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-reportType-eu-lab Laboratory Report Typesdraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-siteQualifier-eu-lab Body Structure Qualifierdraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-specialty-eu-lab Laboratory Specialtydraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-speciesType-eu-vs Types of speciesdraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-specimenAdditive-eu-lab Specimen Additivedraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-specimenContainer-eu-lab Specimen Containerdraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-specimenType-eu-lab Specimen Typesdraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-studyType-eu-lab Laboratory Study Typesdraft2024-12
hl7.fhir.eu.laboratoryR4ValueSet/lab-technique-eu-lab Laboratory Techniquesdraft2024-12
hl7.eu.fhir.xpandh.psR4ConceptMap/allergy2FHIR-eu-ps eHN Allergy to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psR4ConceptMap/closedProblem2FHIR-eu-ps eHN ClosedProblem to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psR4ConceptMap/functionalStatus2FHIR-eu-ps eHN Recipient to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psR4ConceptMap/medicalDevice2FHIR-eu-ps eHN Recipient to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psR4ConceptMap/medicine2FHIR-eu-ps eHN Medicine to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psR4ConceptMap/patientSummary2FHIR-eu-ps eHN Patient Summary to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psR4ConceptMap/pregnancy2FHIR-eu-ps eHN Recipient to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psR4ConceptMap/problem2FHIR-eu-ps eHN Problem to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psR4ConceptMap/procedure2FHIR-eu-ps eHN Recipient to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psR4ConceptMap/result2FHIR-eu-ps eHN Result to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psR4ConceptMap/subject2FHIR-eu-ps eHN Subject to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psR4ConceptMap/vaccination2FHIR-eu-ps eHN Vaccination to this guide Mapdraft2024-12
hl7.eu.fhir.xpandh.psR4ImplementationGuide/hl7.eu.fhir.xpandh.ps XpanDH Patient Summarydraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Allergy A.2.1.1 - Allergydraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/AllergyIntolerance-ps-xpandh Allergy Intolerance (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Bundle-ps-xpandh Bundle (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/CareTeam-eu-xpandh CareTeamdraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/CareTeam-ps-xpandh CareTeam (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/ClosedProblem A.2.2.2 - Resolved, closed or inactive problemsdraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Composition-ps-xpandh Composition (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Condition-ps-xpandh Condition (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Device-ps-xpandh Device (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/DeviceUseStatement-ps-xpandh Device Use Statement (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Flag-ps-xpandh Flag (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/FunctionalStatus A.2.3.3 - Functional Statusdraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Immunization-ps-xpandh Immunization (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/ImmunizationRecommendation-ps-xpandh ImmunizationRecommendation (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Location-ps-xpandh Location (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/MedicalDevice A.2.3.2 - Medical devices and implantsdraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Medication-ps-xpandh Medication (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/MedicationStatement-ps-xpandh Medication Statement (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Medicine A.2.4.1 Current and relevant past medicinesdraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Observation-bloodGrp-xpandh Observation: Blood Groupdraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Observation-results-laboratory-eu-xpandh Observation Results: laboratory (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Observation-results-pathology-eu-xpandh Observation Results: pathology (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Observation-results-radiology-eu-xpandh Observation Results: radiology (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Observation-results-xpandh Observation Results (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Observation-socialHistory-xpandh Observation Social History (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Organization-careprovider-eu-xpandh Organization: Care provisioningdraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Patient-ps-xpandh Patient (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/PatientSummary A - Patient Summarydraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Practitioner-eu-xpandh Practitioner (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/PractitionerRole-eu-xpandh PractitionerRole (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Pregnancy A.2.6 Pregnancy historydraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Problem A.2.3.1 Current problemsdraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Procedure-ps-xpandh Procedure (EU PS)draft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/ProcedurePs A.2.3.3 - Proceduresdraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Result A.2.8 - Resultsdraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Subject A1.1, A1.2 - Subject of caredraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/Vaccination A.2.2.1 - Vaccination/ prophylaxis informationdraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/condition-statusReason Condition Status Reasondraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/immunization-administeredProduct Immunization AdministeredProductdraft2024-12
hl7.eu.fhir.xpandh.psR4StructureDefinition/supportingInformation Supporting Informationdraft2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownAllergy Absent or Unknown Allergiesactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownDevice Absent or Unknown Deviceactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownMedication Absent or Unknown Medicationactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownProblem Absent or Unknown Problemactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIAbsentOrUnknownProcedure Absent or Unknown Procedureactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIActiveIngredient Active Ingredient (PARTIAL)active2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIAdverseEventType Adverse Event Typeactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIAllergenNoDrug Allergen No Drugactive2024-12
hl7.eu.fhir.xpandh.psR4ValueSet/eHDSIAllergens Allergensdraft2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIAllergyCertainty Allergy Certaintyactive2024-12
hl7.eu.fhir.xpandh.psR4ValueSet/eHDSIAllergyCode Allergens or no known or unknown conditionsdraft2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIAllergyStatus Allergy Statusactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIBloodGroup Blood Groupactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIBloodPressure Blood Pressureactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIBodySite Body Siteactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSICertainty Certaintyactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSICodeProb Problemsactive2024-12
hl7.eu.fhir.xpandh.psR4ValueSet/eHDSICondition Conditionsdraft2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIConfidentiality Confidentialityactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSICountry Countryactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSICriticality Criticalityactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSICurrentPregnancyStatus Current Pregnancy Statusactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIDocumentCode Document Codeactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIDoseForm Dose Formactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIHealthcareProfessionalRole Healthcare Professional Roleactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIHospitalDischargeReportType Hospital Discharge Report Typeactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIIllnessandDisorder Illness and Disorder (PARTIAL)active2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIMedicalDevice Medical Device (PARTIAL)active2024-12
hl7.eu.fhir.xpandh.psR4ValueSet/eHDSIProblemCode Problems (including unknown conditions)draft2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIProcedure Procedureactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIRareDisease Rare Disease (PARTIAL)active2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIReactionAllergy Reaction Allergyactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIRouteofAdministration Route of Administrationactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSISeverity Severityactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSISocialHistory eHDSI Social Historyactive2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSISubstance Substance (PARTIAL)active2024-12
hl7.eu.fhir.xpandh.psR4http://terminology.ehdsi.eu/ValueSet/eHDSIVaccine Vaccineactive2024-12
hl7.fhir.eu.hdrR4CodeSystem/assessment-category-eu-hdr Xpandh Assessment Categorydraft2024-12
hl7.fhir.eu.hdrR4CodeSystem/poa-indicator-eu-hdr Present on Admission (POA) Indicatordraft2024-12
hl7.fhir.eu.hdrR4CodeSystem/whodas-20-cs WHO Disability Assessment Schedule 2.0draft2024-12
hl7.fhir.eu.hdrR4ConceptMap/advanceDirectives2FHIR-eu-hdr eHN Advance Directives Model to this guide Mapdraft2024-12
hl7.fhir.eu.hdrR4ConceptMap/alerts2FHIR-eu-hdr eHN Alerts Model to this guide Mapdraft2024-12
hl7.fhir.eu.hdrR4ConceptMap/encounter2FHIR-eu-hdr eHN Encounter Model to this guide Mapdraft2024-12
hl7.fhir.eu.hdrR4ConceptMap/hdr2FHIR-eu-hdr eHN HDR Model to this guide Mapdraft2024-12
hl7.fhir.eu.hdrR4ConceptMap/hdrHeader2FHIR-eu-hdr eHN Header Model to this guide Mapdraft2024-12
hl7.fhir.eu.hdrR4ConceptMap/hospitalStay2FHIR-eu-hdr eHN Hospital Stay Model to this guide Mapdraft2024-12
hl7.fhir.eu.hdrR4ConceptMap/medicationSummary2FHIR-eu-hdr eHN Medication Summary Model to this guide Mapdraft2024-12
hl7.fhir.eu.hdrR4ConceptMap/planOfCare2FHIR-eu-hdr eHN Plan of Care Model to this guide Mapdraft2024-12
hl7.fhir.eu.hdrR4ConceptMap/subject2FHIR-eu-hdr eHN Subject Model to this guide Mapdraft2024-12
hl7.fhir.eu.hdrR4ImplementationGuide/hl7.fhir.eu.hdr HL7 Europe Hospital Discharge Reportdraft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/AdmissionEvaluation A.2.4 - Admission evaluation (eHN)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/AdvanceDirectives A.2.1 - Advance Directives (eHN)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/Alerts A.2.2 - Alerts (eHN)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/DischargeDetails A.2.7 - Discharge details (eHN)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/FunctionalStatus A.2.7.2 - Functional statusdraft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/Header A.1 - Hospital Discharge Report header data elementdraft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/HospitalDischargeReport A - Hospital Discharge Report (eHN)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/HospitalStay A.2.6 - Hospital stay (eHN)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/InPatientEncounter A.2.3 - Encounter (eHN)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/Medication-eu-hdr Medication (HDR)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/MedicationSummary A.2.8.2 - Medication summarydraft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/ObjectiveFindings A.2.7.1 - Objective findingsdraft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/PatientHistory A.2.5 - Patient history (eHN)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/PlanOfCare A.2.8.1 - Care plandraft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/Subject A.1.1 - Identification and A.1.2 - related contact information of the Patient/subjectdraft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/allergyIntolerance-eu-eps Allergy Intolerance (EU PS)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/bundle-eu-hdr Bundle (HDR)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/carePlan-eu-eps Care Plan (HDR)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/composition-eu-hdr Composition (HDR)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/condition-eu-hdr Condition (HDR)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/device-eu-hdr Device (HDR)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/deviceUseStatement-eu-hdr DeviceUseStatement (HDR)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/encounter-eu-hdr Encounter (HDR)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/flag-eu-eps Flag (EU PS)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/location-eu-hdr Location (HDR)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/medicationRequest-eu-hdr MedicationRequest (HDR)draft2024-12
hl7.fhir.eu.hdrR4StructureDefinition/procedure-eu-hdr Procedure (HDR)draft2024-12
hl7.fhir.eu.hdrR4ValueSet/TNM-M-category-vs TNM M Categorydraft2024-12
hl7.fhir.eu.hdrR4ValueSet/TNM-M-clinical-category-vs Clinical Mdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/TNM-M-pathologycal-category-vs Pathological Mdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/TNM-N-category-vs TNM N Categorydraft2024-12
hl7.fhir.eu.hdrR4ValueSet/TNM-N-clinical-category-vs Clinical Ndraft2024-12
hl7.fhir.eu.hdrR4ValueSet/TNM-N-pathological-category-vs Pathological Ndraft2024-12
hl7.fhir.eu.hdrR4ValueSet/TNM-T-category-vs Primary tumor Tdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/TNM-T-clinical-category-vs Clinical Tdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/TNM-T-pathological-category-vs Clinical Tdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/admission-urgency-eu-hdr Admission Urgency Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/admission-voluntary-status-vs Encounter Voluntary Status Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/allergy-intolerance-eu-hdr Allergy Intolerance (with exceptions)draft2024-12
hl7.fhir.eu.hdrR4ValueSet/allergy-intolerance-substances-eu-hdr Allergy Intolerancedraft2024-12
hl7.fhir.eu.hdrR4ValueSet/anthropometric-observation-vs Anthropometric Observation Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/assessment-observation-category-vs Xpandh Assessment Observation Categorydraft2024-12
hl7.fhir.eu.hdrR4ValueSet/bmi-observation-unit-vs BMI Observation Unit Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/bmi-observation-vs BMI Observation Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/body-height-observation-vs Body Height Observation Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/body-weight-observation-vs Body Weight Observation Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/body-weight-units-vs Body Weight Observation Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/cancer-stage-grading-vs Cancer Stage Grading: Snomed CTdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/cancer-stageGroup-vs Cancer Stage Group: SNOMED CTdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/circumference-observation-vs Circumference Observation Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/condition-eu-hdr Condition Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/condition-mandatory-eu-hdr Mandatory Condition Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/encounter-status-eu-hdr In-patient Encounter Type Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/functional-assessment-scales-vs Xpandh Functional Assessment Scalesdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/hdr-encounter-type-eu-hdr In-patient Encounter Type Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/hdr-encounterClass-eu-hdr Encounter Class Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/mcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-12
hl7.fhir.eu.hdrR4ValueSet/mcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-12
hl7.fhir.eu.hdrR4ValueSet/mcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-12
hl7.fhir.eu.hdrR4ValueSet/medical-devices-eu-hdr Medical Devices (SNOMED CT) - Xpandhdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/medical-devices-snomed-absent-unknown-eu-hdr Medical Devices - SNOMED CT + Absent/Unknown - IPSdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/poa-indicator-eu-hdr Condition Present on Admission (POA) Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/procedure-snomed-eu-hdr Procedure codes: Snomed CTdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/procedures-snomed-absent-unknown-eu-hdr Procedures - SNOMED CT + Absent/Unknown - IPSdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/skinfold-thickness-units-vs Skinfold Thickness Units Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/skinfold-thickness-vs Skinfold Thickness Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/treated-problem-eu-hdr Treatment Class Value Setdraft2024-12
hl7.fhir.eu.hdrR4ValueSet/vital-signs-observation-vs Vital Signs Observation Value Setdraft2024-12
hl7.fhir.eu.mpdR4ConceptMap/eD2FHIR-eu-mpd eHN Dispense to this guide Mapdraft2024-12
hl7.fhir.eu.mpdR4ConceptMap/eP2FHIR-eu-mpd eHN Subject to this guide Mapdraft2024-12
hl7.fhir.eu.mpdR4ConceptMap/medProd2FHIR-eu-mpd eHN Medicinal Product to this guide Mapdraft2024-12
hl7.fhir.eu.mpdR4ImplementationGuide/hl7.fhir.eu.mpd HL7 Europe Medication Prescription and Dispensedraft2024-12
hl7.fhir.eu.mpdR4StructureDefinition/Dispensation B.1 Dispensation information (provided by the dispensing pharmacy)draft2024-12
hl7.fhir.eu.mpdR4StructureDefinition/Medication-eu-mpd Medication: MPDdraft2024-12
hl7.fhir.eu.mpdR4StructureDefinition/MedicationDispense-eu-mpd MedicationDispense: MPDdraft2024-12
hl7.fhir.eu.mpdR4StructureDefinition/MedicationRequest-eu-mpd MedicationRequest: MPDdraft2024-12
hl7.fhir.eu.mpdR4StructureDefinition/MedicinalProduct A1.4 Identification of the prescribed productdraft2024-12
hl7.fhir.eu.mpdR4StructureDefinition/Prescription A - Prescriptiondraft2024-12
hl7.fhir.eu.mpdR4StructureDefinition/Subject A.1.1 Patient administrative datadraft2024-12
hl7.eu.fhir.xpandhR4ImplementationGuide/hl7.eu.fhir.xpandh XpanDH Projectdraft2024-12
hl7.eu.fhir.xpandhR4StructureDefinition/Patient-eu-xpandh Patient: XpanDHdraft2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIAbsentOrUnknownAllergy Absent or Unknown Allergiesactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIAbsentOrUnknownDevice Absent or Unknown Deviceactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIAbsentOrUnknownMedication Absent or Unknown Medicationactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIAbsentOrUnknownProblem Absent or Unknown Problemactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIAbsentOrUnknownProcedure Absent or Unknown Procedureactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIAdverseEventType Adverse Event Typeactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIAllergenNoDrug Allergen No Drugactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIAllergyCertainty Allergy Certaintyactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIAllergyStatus Allergy Statusactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIBloodGroup Blood Groupactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIBloodPressure Blood Pressureactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSICertainty Certaintyactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSICodeProb Problemsactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIConfidentiality Confidentialityactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSICountry Countryactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSICriticality Criticalityactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSICurrentPregnancyStatus Current Pregnancy Statusactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIDocumentCode Document Codeactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIDoseForm Dose Formactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIHealthcareProfessionalRole Healthcare Professional Roleactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIHospitalDischargeReportType Hospital Discharge Report Typeactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIProcedure Procedureactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIReactionAllergy Reaction Allergyactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSISeverity Severityactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSISocialHistory eHDSI Social Historyactive2024-12
hl7.eu.fhir.xpandhR4ValueSet/eHDSIVaccine Vaccineactive2024-12
hl7.eu.fhir.ghepiR5ImplementationGuide/hl7.eu.fhir.ghepi Gravitate Health FHIR Implementation Guideactive2024-10
hl7.eu.fhir.pcspR4CodeSystem/cs-generic-eu-pcsp PCSP Code Systemdraft2024-12
hl7.eu.fhir.pcspR4CodeSystem/cs-radiotherapy-pcsp Radiotherapy sitesactive2024-12
hl7.eu.fhir.pcspR4CodeSystem/cs-recommendation-eu-pcsp PCSP Recommendationsdraft2024-12
hl7.eu.fhir.pcspR4CodeSystem/cs-riskcondition-eu-pcsp PCSP Conditions at riskdraft2024-12
hl7.eu.fhir.pcspR4CodeSystem/cs-riskfactor-eu-pcsp Risk Factorsdraft2024-12
hl7.eu.fhir.pcspR4ImplementationGuide/hl7.eu.fhir.pcsp PanCareSurPass Project HL7 FHIR Implementation Guidedraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/BiologicallyDerivedProduct-sct-eu-pcsp BiologicallyDerivedProduct: Stem Celldraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Bundle-eu-pcsp Bundle: Survivor Passportdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/CarePlan-eu-pcsp CarePlan: PCSP-generated plandraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Chemotherapy Chemotherapydraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Composition-surpass-eu-pcsp Composition: Survivor Passportdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Condition-gvhd-eu-pcsp Condition: GvHDdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Condition-otherinfos-eu-pcsp Condition: Othersdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Condition-primaryCancer-eu-pcsp Condition: Primary Cancerdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Condition-secondaryCancer-eu-pcsp Condition: Metastatic Cancerdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Condition-toxicity-eu-pcsp Condition: Severe Toxicitydraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Diagnosis Diagnosisdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/DocMetadataFSE Metadata FSE Italydraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/DocumentReference-eu-pcsp DocumentReference: PCSPdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Encounter-eu-pcsp Encounter: Treatment Centerdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/FrontLineTreatment Front Line Treatmentdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Location-eu-pcsp Location: PCSPdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/MajorSurgery Major Surgerydraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/MedicationAdministration-eu-pcsp MedicationAdministration: Chemotherapydraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/MedicationStatement-eu-pcsp MedicationStatement: Chemotherapydraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Observation-bld-abo-rh-eu-pcsp Observation: Blood type/RHdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Observation-cumulativeDoseChemo-eu-pcsp Observation: Chemotherapy Cumulative Dosedraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Observation-diagnosis-eu-pcsp Observation: Diagnosis detailsdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Observation-predisposition-eu-pcsp Observation: Hereditary Predispositiondraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Observation-riskfactor-eu-pcsp Observation: Risk Factordraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Observation-totalDoseRad-eu-pcsp Observation: Radiotherapy Total Dose PCSPdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Organization-center-eu-pcsp Organization: Primary Treatment Center / Center of diagnosisdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/OtherInfos Other info and relevant eventsdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Patient-eu-pcsp Patient: PCSPdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/PlanDefinition-flt-eu-pcsp PlanDefinition: Front Line Treatmentdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/PlanOfCare Care Plandraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-cryopreservation-otherinfos-eu-pcsp Procedure: Cryopreservationdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-cvc-otherinfos-eu-pcsp Procedure: Catheterdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-flt-eu-pcsp Procedure: Front Line Treatmentdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-radiotheraphy-eu-pcsp Procedure: Radiotherapydraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-radiotheraphyBoost-eu-pcsp Procedure: Radiotherapy Boostdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-radiotheraphyShield-eu-pcsp Procedure: Radiotherapy Shieldingdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-sct-eu-pcsp Procedure: Stem Cell Transplantationdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-sct-prophylaxis-eu-pcsp Procedure: SCT Prophylaxisdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-surgery-eu-pcsp Procedure: Surgerydraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-transfusion-otherinfos-eu-pcsp Procedure: Transfusion other infosdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Procedure-treatment-otherinfos-eu-pcsp Procedure: Other Treatmentsdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Radiotherapy Radiotherapydraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/RelapseAfterFLT Progression-Relapse after FLTdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/RelapseDuringFLT Progression-Relapse during FLTdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/StemCellTransplantation Stem Cell Transplantationdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/Subject Subject of caredraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/SurPass SurPass V2.0draft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/TreatmentSummary Treatment Summarydraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/annotation-type Annotation Typedraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/condition-previousStatus Previous Statusdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/condition-relapseType Relapse Typedraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/event-location Act Locationdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/mcode-body-location-qualifier Body Location Qualifierdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/mcode-cancer-stage-group Observation: Cancer Stage Groupdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/mcode-condition-related Condition related to resourcedraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/mcode-laterality-qualifier Laterality Qualifierdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/mcode-tnm-distant-metastases-category Observation: TNM Distant Metastases Categorydraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/mcode-tnm-primary-tumor-category Observation: TNM Primary Tumor Categorydraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/mcode-tnm-regional-nodes-category Observation: TNM Regional Nodes Categorydraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/procedure-fltArm Randomization arm for trialdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/procedure-notAffectedOrgan Not affected Organdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/procedure-performedTiming Performed Timingdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/procedure-usedReference Procedure Used Referencedraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/radiotherapy-energy-or-isotope Radiotherapy Energy or Isotopedraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/resource-relatedInfo Resource related informationdraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/sct-donor-type Stem Cell Donor Typedraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/sct-source-type Stem Cell Source Typedraft2024-12
hl7.eu.fhir.pcspR4StructureDefinition/surgery-sacrifiedOrgan Sacrified organdraft2024-12
hl7.eu.fhir.pcspR4ValueSet/ChemoUnitsVs Chemotherapy cumulative dose unitsdraft2024-12
hl7.eu.fhir.pcspR4ValueSet/activeResolved-condition-vs Active or resolved Conditiondraft2024-12
hl7.eu.fhir.pcspR4ValueSet/annotation-type-vs Annotation typedraft2024-12
hl7.eu.fhir.pcspR4ValueSet/cond-test-vs Conditions: follow updraft2024-12
hl7.eu.fhir.pcspR4ValueSet/drugsAtc-eu-pcsp Antineoplastic and immunostimulating agentsdraft2024-12
hl7.eu.fhir.pcspR4ValueSet/grade-test-vs Grade: follow updraft2024-12
hl7.eu.fhir.pcspR4ValueSet/laterality-qualifier-lrub-vs Laterality Qualifier Value Setdraft2024-12
hl7.eu.fhir.pcspR4ValueSet/mcode-body-location-qualifier-vs Body Location Qualifier Value Setdraft2024-12
hl7.eu.fhir.pcspR4ValueSet/mcode-cancer-stage-group-vs Stage Group Value Setdraft2024-12
hl7.eu.fhir.pcspR4ValueSet/mcode-cancer-staging-system-vs Cancer Staging System Value Setdraft2024-12
hl7.eu.fhir.pcspR4ValueSet/mcode-observation-codes-distant-metastases-vs Observation Codes for Distant Metastases Categorydraft2024-12
hl7.eu.fhir.pcspR4ValueSet/mcode-observation-codes-primary-tumor-vs Observation Codes for Primary Tumor Categorydraft2024-12
hl7.eu.fhir.pcspR4ValueSet/mcode-observation-codes-regional-nodes-vs Observation Codes for Regional Node Categorydraft2024-12
hl7.eu.fhir.pcspR4ValueSet/mcode-observation-codes-stage-group-vs Observation Codes for Stage Group Categorydraft2024-12
hl7.eu.fhir.pcspR4ValueSet/mcode-tnm-distant-metastases-category-vs TNM Distant Metastases Category Value Setdraft2024-12
hl7.eu.fhir.pcspR4ValueSet/mcode-tnm-primary-tumor-category-vs TNM Primary Tumor Category Value Setdraft2024-12
hl7.eu.fhir.pcspR4ValueSet/mcode-tnm-regional-nodes-category-vs TNM Regional Nodes Category Value Setdraft2024-12
hl7.eu.fhir.pcspR4ValueSet/morphologicAbnormality-eu-vs Morphologically abnormal structuredraft2024-12
hl7.eu.fhir.pcspR4ValueSet/otherInfos-condition-vs Other Infors Conditiondraft2024-12
hl7.eu.fhir.pcspR4ValueSet/relapse-type-vs Relapse type (Local/Distant/Combined)draft2024-12
hl7.eu.fhir.pcspR4ValueSet/toxicityseverity-vs Toxicity Severitydraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-Gvhd-acute-grade-eu-pcsp Acute Gvhd Gradedraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-Gvhd-chronic-grade-eu-pcsp Chronic Gvhd conditiondraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-Gvhd-type-eu-pcsp Gvhd conditiondraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-ProsthesisType-eu-pcsp Prosthesis Typedraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-ProstheticProcedureType-eu-pcsp Prosthetic Surgical Procedure Typedraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-action-eu-pcsp Surgical Actionsdraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-affectedOrgan-eu-pcsp Affected Organs (surgery)draft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-amputationProcedureType-eu-pcsp Amputation Surgical Procedure Typedraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-brachytherapyType-eu-pcsp Brachytherapy Typedraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-calcest-eu-pcsp Calculated|Estimateddraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-colostomyProcedureType-eu-pcsp Colostomy Surgical Procedure Typedraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-docref-doctype-eu-pcsp Document Typedraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-flt-plan-type-eu-pcsp FLT Plan Typedraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-fromToPosteriorAnterior-eu-pcsp Body Location Qualifier Value Setdraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-gastrostomyProcedureType-eu-pcsp Gastrostomy Surgical Procedure Typedraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-hereditary-eu-pcsp Hereditary Predispositions or Diseasedraft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-iccc3-eu-pcsp ICCC-3draft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-icd10-predisposition-eu-pcsp Hereditary Predispositions (ICD10)draft2024-12
hl7.eu.fhir.pcspR4ValueSet/vs-icdo3-morphology-eu-pcsp ICD-O-3 Morphologydraft2024-12

XIG built as of 17 Dec 2024. Found 40236 resources in 710 packages.